Sunday, January 24, 2021 10:52:34 AM
Work on your math 'hotmeat' $0.50 to $0.70 is 40% and Revive took a 20% haircut on the announcement. Creating doubt for other investors? How does benefit me? I'm invested here and reloaded @ $0.49 as novice investors and shorts sold/dumped on news; again as long as the directive doesn't align with you it's wrong?
It's a sh1t deal knowing what's in the pipeline and yes! MF just proved that he is either a rookie, desperate or had another motive, raising money below the weighted average is a rookie move; like it or lump it.
It's a sh1t deal knowing what's in the pipeline and yes! MF just proved that he is either a rookie, desperate or had another motive, raising money below the weighted average is a rookie move; like it or lump it.
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
